+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast to 2030- Product Image
Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast to 2030- Product Image
Sale

Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5204994
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Medicine Market grew from USD 45.51 billion in 2024 to USD 49.10 billion in 2025. It is expected to continue growing at a CAGR of 7.74%, reaching USD 71.22 billion by 2030.

Setting the Stage for Veterinary Medicine Market Dynamics

The veterinary medicine market stands at a pivotal moment, shaped by evolving healthcare needs, technological advancements, and shifting regulatory environments. This executive summary lays the groundwork for understanding key forces driving growth and disruption across companion animal, equine, and livestock sectors. By establishing the scope-encompassing diagnostics, feed additives, pharmaceuticals, and vaccines across multiple therapeutic areas and routes of administration-it underscores the complex interplay between animal health and broader agricultural and pet care industries.

Objectives include highlighting transformative trends, evaluating the impact of policy shifts, uncovering segmentation-driven growth pockets, and identifying regional nuances. The analysis delivers strategic clarity for decision-makers seeking to navigate rising cost pressures, supply chain realignment, and intensifying competition. Ultimately, this introduction frames the critical context for readers to grasp how market dynamics are shaping research priorities, commercialization strategies, and partnership models in veterinary healthcare.

Emerging Forces Redefining Veterinary Care Paradigms

Breakthroughs in digital diagnostics, precision therapies, and telehealth are redefining how veterinary services are delivered and consumed. Artificial intelligence-driven imaging platforms are accelerating disease detection, while data analytics enable practitioners to tailor treatment protocols to individual animals, enhancing efficacy and reducing adverse effects. Concurrently, the humanization of pets continues to fuel demand for advanced biologics, mirroring trends in human healthcare pipelines.

E-commerce channels have surged, transforming the distribution paradigm and intensifying competition among online stores, pharmacies, and clinics. Supply chains are also experiencing a shift toward on-shoring manufacturing capabilities to mitigate disruptions, boosting investments in regional production facilities. Regulatory agencies are responding with streamlined approval pathways for novel vaccines and therapeutics, yet heightened scrutiny on antimicrobial stewardship is reshaping pharmaceutical development strategies.

Together, these forces create a landscape where agility and innovation determine market leadership. Stakeholders must embrace digital integration, foster cross-sector collaboration, and anticipate regulatory recalibrations to capitalize on emerging growth vectors.

Unpacking the Ripple Effects of 2025 Tariff Revisions

The U.S. government’s tariff revisions in 2025 impose higher duties on select pharmaceutical APIs, diagnostic instruments, and raw materials critical to veterinary medicine. These measures have reverberated through global supply chains, prompting manufacturers to revisit sourcing strategies and absorb incremental cost pressures. Higher import duties on imaging equipment have translated into pricing adjustments for veterinary practices, compelling many to delay capital investments or explore leasing arrangements.

Feed additive producers face margin contractions as imported medicated premixes incur steeper tariffs, driving demand for domestically produced formulations. Pharmaceutical companies are negotiating longer-term contracts with API suppliers to stabilize input costs, while vaccines producers are reexamining batch sizes and shipping schedules to minimize duty liabilities. Downstream distribution channels-including online retailers and brick-and-mortar pharmacies-are recalibrating their inventory models, balancing turnover rates against holding costs in a higher-tariff environment.

Clinics and hospitals are contending with rising overheads, leading to modest fee increases for pet owners and livestock operators. In response, industry players are accelerating investments in cost-efficient technologies and exploring alternative raw material sources in low-tariff jurisdictions. This cumulative impact underscores the urgent need for strategic agility and resilient supply chain design.

Navigating Market Segments for Targeted Growth Opportunities

A nuanced understanding of market segmentation reveals where growth and innovation intersect. In the animal type domain, demand for advanced therapeutics has surged within dogs and cats, driven by increased pet ownership and rising expenditure on bespoke treatments, while equine care continues to benefit from elite performance markets and specialized veterinary services. Livestock segments such as poultry and swine prioritize cost-effective medicated feed additives to enhance productivity, whereas the cattle sector emphasizes vaccine regimes to curb disease outbreaks.

Product type analysis highlights that diagnostics, particularly imaging modalities and infectious disease assays, are gaining traction as veterinarians seek rapid, point-of-care solutions. Medicated feed additives remain essential for large-scale animal operations, but pharmaceuticals encompassing generics, over-the-counter remedies, and prescription drugs are experiencing differentiated growth rates based on formulary expansions and patent expirations. Within vaccines, the shift toward recombinant platforms complements enduring demand for inactivated and live attenuated formulations.

Distribution channel dynamics show a steady migration of end users toward digital storefronts, though pharmacies and veterinary clinics retain their status as trusted access points for critical therapies. Therapeutic area trends emphasize anti-infectives-antibiotics, antifungals, antivirals-and parasiticides addressing external and systemic parasites, while anti-inflammatories and cardiovascular treatments carve out specialized niches. Finally, route of administration considerations, spanning inhalation, injectable, oral, and topical modalities, influence product development priorities and adoption curves across clinical and field settings.

Regional Market Nuances Shaping Global Strategies

Regional distinctions underscore the importance of tailored strategies. In the Americas, robust pet ownership rates and progressive reimbursement models underpin strong growth in companion animal therapeutics and diagnostics, while the livestock sector benefits from integrated supply chains and biosecurity investments. The Europe, Middle East & Africa region exhibits varied regulatory landscapes, with the European Union driving harmonized standards for vaccine approvals and antimicrobial stewardship, even as emerging markets in the Middle East and Africa focus on expanding basic veterinary infrastructure.

Asia-Pacific stands out for its dual trajectory: rapid modernization of livestock operations in China and Southeast Asia, alongside burgeoning demand for premium pet healthcare in urban centers. Local manufacturers are forging partnerships to align with global quality benchmarks, and e-commerce platforms are penetrating rural markets where access to veterinary products has been historically limited. These regional insights highlight the need for flexible market entry models, dynamic pricing structures, and collaboration with local stakeholders to navigate diverse regulatory and economic environments.

Competitive Landscape and Strategic Company Profiles

Leading pharmaceutical and diagnostics firms maintain competitive advantages through diversified portfolios that span feed additives, generics, and cutting-edge biologics. Strategic acquisitions have allowed some players to integrate imaging technologies and point-of-care testing into their offerings, creating end-to-end solutions for veterinary practitioners. Partnerships between vaccine developers and contract manufacturing organizations have accelerated scale-up capabilities, particularly for recombinant and live attenuated platforms.

A wave of joint ventures is emerging across regions, aligning global R&D expertise with local market insights. Companies are investing heavily in digital platforms for telehealth consultations, remote monitoring implants, and data analytics, leveraging real-world evidence to refine product positioning and dosing regimens. Competitive intelligence indicates that firms with robust animal health divisions are reallocating resources toward precision therapies, while smaller innovators focus on niche indications such as exotic species care or advanced wound management.

This evolving landscape underscores the imperative for continuous portfolio optimization and strategic agility. Companies that anticipate shifting customer preferences and regulatory directives will capture disproportionate market share.

Strategic Imperatives to Drive Value Creation

Industry leaders should prioritize digital transformation initiatives that integrate telehealth, remote diagnostics, and cloud-based data analytics to enhance service delivery and foster customer loyalty. Diversifying supply chains by establishing regional manufacturing hubs will mitigate tariff exposure and strengthen resilience against future policy shifts. Firms must also pursue targeted R&D investments in high-growth segments-such as recombinant vaccines and novel antiparasitic agents-while forging collaborations with academic institutions to accelerate time-to-market.

Cultivating strategic alliances with e-commerce platforms and veterinary networks will ensure broad product accessibility and streamline distribution. Engaging proactively with regulatory bodies can expedite approval pathways and shape guidelines in emerging therapeutic areas. Moreover, adopting flexible pricing models, including subscription-based services for diagnostics and chronic care, will align value propositions with evolving customer expectations.

By embedding sustainability considerations across product life cycles and supply chain operations, companies can address growing stakeholder demands for environmental stewardship. These actionable imperatives will position industry participants to capitalize on shifting market dynamics and drive sustained value creation.

Rigorous Framework Underpinning the Research Process

This research employs a multilayered methodology that integrates comprehensive secondary research with primary data collection and expert validation. Secondary sources include regulatory filings, industry journals, corporate presentations, and reputable databases, which provide historical context and benchmark data. Primary insights are gathered through structured interviews with veterinary practitioners, livestock producers, pharmaceutical executives, and regulatory specialists, ensuring a balanced perspective across stakeholder groups.

Data triangulation techniques reconcile discrepancies between sources and reinforce the reliability of key findings. Market segmentation and regional analyses are derived from a bottom-up approach, correlating end-user consumption patterns with supply chain metrics and policy developments. Quality assurance protocols involve peer reviews by subject-matter experts and statistical validation to detect anomalies.

This rigorous framework ensures that the report’s conclusions reflect the most current industry trends, actionable insights, and strategic considerations, providing decision-makers with a robust foundation for informed planning and investment.

Concluding Insights and Future Outlook

In summary, the veterinary medicine market is undergoing a profound evolution driven by digital innovation, regulatory realignments, and shifting consumer behaviors. The 2025 tariff adjustments have accentuated the need for supply chain resilience, while segmentation insights reveal distinct growth trajectories across animal types, product categories, and therapeutic areas. Regional dynamics underscore the importance of adaptive market entry strategies and localized partnerships, and competitive analysis highlights a clear divide between integrated global players and specialized niche innovators.

Moving forward, stakeholders who embrace digital platforms, fortify supply chains, and engage collaboratively with regulatory authorities will secure leadership positions. The synthesis of this executive summary provides a cohesive roadmap for navigating emerging challenges and capitalizing on growth opportunities in veterinary healthcare. As the industry advances, ongoing vigilance and strategic foresight will be paramount to sustaining momentum and driving innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Companion Animal
      • Cat
      • Dog
    • Equine
      • Horse
    • Livestock
      • Cattle
      • Poultry
      • Swine
  • Product Type
    • Diagnostics
      • Imaging
      • Infectious Disease
    • Medicated Feed Additives
    • Pharmaceuticals
      • Generic Drugs
      • Over The Counter Drugs
      • Prescription Drugs
    • Vaccines
      • Inactivated
      • Live Attenuated
      • Recombinant
  • Distribution Channel
    • Online Stores
    • Pharmacies
    • Veterinary Clinics
  • Therapeutic Area
    • Anti Infectives
      • Antibiotics
      • Antifungals
      • Antivirals
    • Anti Inflammatories
    • Cardiovascular
    • Parasiticides
      • Ectoparasiticides
      • Endectocides
  • Route Of Administration
    • Inhalation
    • Injectable
    • Oral
    • Topical
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories, Inc.
  • Ceva Santé Animale S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Dechra Pharmaceuticals plc
  • Phibro Animal Health Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Medicine Market, by Animal Type
8.1. Introduction
8.2. Companion Animal
8.2.1. Cat
8.2.2. Dog
8.3. Equine
8.3.1. Horse
8.4. Livestock
8.4.1. Cattle
8.4.2. Poultry
8.4.3. Swine
9. Veterinary Medicine Market, by Product Type
9.1. Introduction
9.2. Diagnostics
9.2.1. Imaging
9.2.2. Infectious Disease
9.3. Medicated Feed Additives
9.4. Pharmaceuticals
9.4.1. Generic Drugs
9.4.2. Over The Counter Drugs
9.4.3. Prescription Drugs
9.5. Vaccines
9.5.1. Inactivated
9.5.2. Live Attenuated
9.5.3. Recombinant
10. Veterinary Medicine Market, by Distribution Channel
10.1. Introduction
10.2. Online Stores
10.3. Pharmacies
10.4. Veterinary Clinics
11. Veterinary Medicine Market, by Therapeutic Area
11.1. Introduction
11.2. Anti Infectives
11.2.1. Antibiotics
11.2.2. Antifungals
11.2.3. Antivirals
11.3. Anti Inflammatories
11.4. Cardiovascular
11.5. Parasiticides
11.5.1. Ectoparasiticides
11.5.2. Endectocides
12. Veterinary Medicine Market, by Route Of Administration
12.1. Introduction
12.2. Inhalation
12.3. Injectable
12.4. Oral
12.5. Topical
13. Americas Veterinary Medicine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Veterinary Medicine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Veterinary Medicine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Merck & Co., Inc.
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Elanco Animal Health Incorporated
16.3.5. IDEXX Laboratories, Inc.
16.3.6. Ceva Santé Animale S.A.
16.3.7. Vetoquinol S.A.
16.3.8. Virbac S.A.
16.3.9. Dechra Pharmaceuticals plc
16.3.10. Phibro Animal Health Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VETERINARY MEDICINE MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY MEDICINE MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY MEDICINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VETERINARY MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 86. CANADA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 87. CANADA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 88. CANADA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. CANADA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 91. CANADA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 92. CANADA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. CANADA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. CANADA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 95. CANADA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 96. CANADA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 99. MEXICO VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 101. MEXICO VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. MEXICO VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. GERMANY VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 165. GERMANY VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 167. GERMANY VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. GERMANY VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 171. GERMANY VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. GERMANY VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 173. GERMANY VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 174. GERMANY VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 175. GERMANY VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 178. FRANCE VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 180. FRANCE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 184. FRANCE VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. FRANCE VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 186. FRANCE VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 187. FRANCE VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 188. FRANCE VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 204. ITALY VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 205. ITALY VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 206. ITALY VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ITALY VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. ITALY VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 209. ITALY VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 210. ITALY VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. ITALY VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 212. ITALY VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 213. ITALY VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 214. ITALY VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. SPAIN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 217. SPAIN VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 219. SPAIN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SPAIN VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 223. SPAIN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SPAIN VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 225. SPAIN VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 226. SPAIN VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 227. SPAIN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. DENMARK VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 269. DENMARK VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 270. DENMARK VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 271. DENMARK VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. DENMARK VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 275. DENMARK VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. DENMARK VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 277. DENMARK VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 278. DENMARK VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 279. DENMARK VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. QATAR VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 295. QATAR VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 296. QATAR VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 297. QATAR VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. QATAR VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 299. QATAR VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 300. QATAR VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 301. QATAR VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. QATAR VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 303. QATAR VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 304. QATAR VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 305. QATAR VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. FINLAND VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 307. FINLAND VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 308. FINLAND VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 310. FINLAND VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. FINLAND VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 312. FINLAND VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 313. FINLAND VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 314. FINLAND VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. FINLAND VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 316. FINLAND VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 317. FINLAND VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 318. FINLAND VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 3

Companies Mentioned

The companies profiled in this Veterinary Medicine market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories, Inc.
  • Ceva Santé Animale S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Dechra Pharmaceuticals plc
  • Phibro Animal Health Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 49.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 71.22 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 258 Pages
  • Global
From
Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030 - Product Image

Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030

  • Report
  • 190 Pages
  • China, Global
From
Veterinary Orthopedic Medicines Market Size, Share & Trends Analysis Report by Product, Animal Type, Application, Route Of Administration, End Use, Region, and Segment Forecasts, 2024-2030 - Product Image

Veterinary Orthopedic Medicines Market Size, Share & Trends Analysis Report by Product, Animal Type, Application, Route Of Administration, End Use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 183 Pages
  • Global
From
Veterinary Lasers Market by Technology, Power Range, Treatment Type, Distribution Channel, Application, End User, Animal Type - Global Forecast to 2030 - Product Image

Veterinary Lasers Market by Technology, Power Range, Treatment Type, Distribution Channel, Application, End User, Animal Type - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Veterinary Medicines - Global Strategic Business Report - Product Image

Veterinary Medicines - Global Strategic Business Report

  • Report
  • 64 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.